Reversal of multidrug resistance in K562/A02 cells by oxymatrine

Chinese Journal of Clinical Oncology

Volumn 35, Issue 19, 2008, Pages 1127-1130

  Peng, Xiangqian ^a   Zhang, Wenhui ^a   Li, Jun ^b  

^a LIAOCHENG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

K562 A02 cell; Multidrug resistance; Oxymatrine

Indexed keywords

DAUNORUBICIN; DOXORUBICIN; GLYCOPROTEIN; GLYCOPROTEIN 170; OXYMATRINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STRAIN K 562; COLORIMETRY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; LEUKEMIA; LEUKEMIA CELL; LOW DRUG DOSE; MULTIDRUG RESISTANCE;

EID: 77951553981     PISSN: 16727118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Hill S,Rein DT, Riffelmann M, et al. Anticancer drugs induce mdr 1 gene expression in recurrent ovarian cancer[J]. Anticancer Drugs,2006, 17(9): 1041-1044.
2. Arora A, Seth K, Shukla Y. Reversal of P-glycoprotein-mediated multidrug resistance by diallyl sulfide in K562 leukemic cells and in mouse liver[J]. Carcinogenesis, 2004, 25(6): 941-949. (Pubitemid 38886080)
3. Norgaard JM, Olesen LH, Hokland P. Changing picture of cellular drug resistance in human leukemia[J]. Crit Rev Oncol Hematol, 2004, 50(1): 39-49. (Pubitemid 38501616)